Skip to main content
Log in

Die Infektion des Menschen mit Mycobacterium ulcerans (Buruli-Ulkus)

  • Übersicht
  • Published:
Infection Aims and scope Submit manuscript

Zusammenfassung

Das Buruli-Ulkus wird durch Mycobacterium ulcerans, ein salzsäure-alkoholfestes Stäbchenbakterium, verursacht. Es findet sich vorwiegend an den Extremitäten als chronisches Ulkus mit weit unterminierten Rändern und ausgedehnten Nekrosen des subkutanen Fettgewebes. Die Heilungstendenz ist schlecht. Die Infektionskrankheit wird hauptsächlich bei Kleinkindern und Jugendlichen beobachtet. Das Auftreten der Erkrankung ist an eine mittlere Jahrestemperatur von 23°C gebunden; es handelt sich demnach um eine tropische Infektionskrankheit. Das Ulkus wurde, mit Ausnahmen, nur bei Farbigen beschrieben. Die Inkubationszeit der Erkrankung beträgt 4–13 Wochen; ihre Epidemiologie, der Infektionsmodus und die Frage einer Resistenz des Menschen und einer möglichen Immunität sind noch ungeklärt. Im Tierversuch können mit M. ulcerans vorzugsweise Ratten und Mäuse infiziert werden. Als Chemotherapeutikum der Wahl gilt heute das Riminophenazon-Derivat Lampren®.

Summary

Buruli ulcer is caused by Mycobacterium ulcerans, an acid-fast (HCl), alcohol-fast, rodshaped bacillus. It occurs mainly in the extremities as a chronic ulcer with considerably undermined margins and extensive necroses of the subcutaneous fatty tissues. The tendency to heal is poor. The infection is observed principally in small children and juveniles. The appearance of the disease is bound up with a mean annual temperature of 23°C. It is therefore a tropical infectious disease. With exceptions, the ulcer has only been described in coloured persons. The incubation period for the disease is 4 to 13 weeks, its epidemiology, mode of infection and the question of a resistance in humans and a possible immunity are still not known. In animal experiments with M. ulcerans, rats and mice can be infected preferentially. The chemotherapeutic agent of choice today is the riminophenazine derivative, Lamprene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Schrifttum

  1. Aguilar, P. L., Iturribarria, F. M. u.Middlebrook, G. Un caso de infeccion humana por Mycobacterium ulcerans en el hemisferio occidental. Nota previa. Int. J. Leprosy 21 (1953) 469–476.

    Google Scholar 

  2. Barker, D. J. P., Clancey, J. K., Morrow, R. H. andRao, S. Transmission of Buruli disease. Brit. med. J. (1970/IV) 558 (Correspondence).

    Google Scholar 

  3. Barry, V. C., Belton, J. G., Conalty, M. L., Denneny, J. M., Edward, D. W., O'Sullivan, J. F., Twomey, D. andWinder, F. A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature, London, 179 (1957) 1013–1015.

    Google Scholar 

  4. Barry, V. C. andConalty, M. L. Antituberculosis activity in the phenazine series. II.N3-substituted anilinoaposafranines (rimino-compounds) and some derivatives. Amer. Rev. Tuberc. 78 (1958) 62–73.

    Google Scholar 

  5. Barry, V. C. andConalty, M. L. The antimycobacterial activity of B 663. Lep. Rev. 36 (1965) 3–7.

    Google Scholar 

  6. Basset. A. Tropical phagedenic ulcer. In: Essays on tropical dermatology. Hrsg. vonR. D. G. Ph. Simons andJ. Marshall, S. 25. 33. Excerpta Medica Foundation, Amsterdam 1969.

    Google Scholar 

  7. Bayley, A. C. Buruli ulcer in Ghana. Brit. Med. J. (1971/II) 401–402 (Correspondence).

    Google Scholar 

  8. Bergey's Manual of Determinative Bacteriology. 7. Aufl., S. 700–701. Baltimore 1957.

  9. Bradley, D. J., Hutt, M. S. R., Revill, W. D. L. andKiryabwire, J. W. M., and the other members of the Uganda Buruli Group: Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Brit. med. J. (1970/II) 390–393.

    Google Scholar 

  10. Browne, S. G. andHogerzeil, L. M. „B 663“ in the treatment of leprosy. Preliminary report of a pilot trial. Lep. Rev. 33 (1962) 6–10.

    Google Scholar 

  11. Browne, S. G. Red and black pigmentation developing during treatment of leprosy with “B 663”. Lep. Rev. 36 (1965) 17–20.

    Google Scholar 

  12. Clancey, J. K., Dodge, O. G., Lunn, H. F. andOduori, M. L. Mycobacterial skin ulcers in Uganda. Lancet (1961/II) 951–954.

    Google Scholar 

  13. Clancey, J. K. Mycobacterial skin ulcers in Uganda: Description of a new Mycobacterium (Mycobacterium buruli). J. Path. Bact. 88 (1964) 175–187.

    Google Scholar 

  14. Connor, D. H. andLunn, H. F. Buruli-ulceration. Arch. Path. 81 (1966) 183–199.

    Google Scholar 

  15. Davey, W. W. Companion to surgery in Africa. Kap. IV, S. 27–28. E. & S. Livingstone Ltd., Edinburgh — London 1968.

    Google Scholar 

  16. De Souza-Araujo, H. C. Possible transmission of Mycobacterium leprae by biting arthropods. Trans. Roy. Soc. Trop. Med. Hyg. 55 (1961) 556–557.

    Google Scholar 

  17. Dodge, O. G. andLunn, H. F. Buruli ulcera: a mycobacerial skin ulcer in an Uganda child. J. Trop. Med. Hyg. 65 (1962) 139–142.

    Google Scholar 

  18. Dodge, O. G. Mycobacterial skin ulcers in Uganda: Histopathological and experimental aspects. J. Path. Bact. 88 (1964) 167–174.

    Google Scholar 

  19. Farber, E. R. andTsang, A. Mycobacterial (“Buruli”) ulcer in a Peace Corps worker. Arch. Surg. 95 (1967) 297–300.

    Google Scholar 

  20. Gray, H. H., Kingma, S. andKok, S. H. Mycobacterial skin ulcers in Nigeria. Trans. Roy. Soc. Trop. Med. Hyg. 61 (1967) 712–714.

    Google Scholar 

  21. Janssens, P. G., Quertinmont, M. J., Sieniawski, J. andGatti, F. Necrotic tropical ulcers and mycobacterial causative agents. Trop. Geograph. Med. 11 (1959) 293–312.

    Google Scholar 

  22. Jelliffe, D. B. Diseases of children in the Subtropics and Tropics. 2nd Edition. S. 621–624. Edward Arnold (Publishers) Ltd., London 1970.

    Google Scholar 

  23. Kieninger, G., Schubert, G. E., Ullmann, U., Höfler, W. u.Fouad, Z. Das Buruli-Ulkus. Z. Tropenmed. Parasit. 23 (1972) 342–355.

    Google Scholar 

  24. Languillon, J. Action de deux nouveaux produits, la thalidomide et le B. 663, sur les formes réactionelles de la maladie de Hansen. Méd. Trop. 29 (1969) 497–503.

    Google Scholar 

  25. Lucas, A. O. Clinical features of Mycobacterium ulcerans infection. Hrsg. vom Department of Preventive and Social Medicine, University College Hospital, Ibadan, Nigeria 1969.

    Google Scholar 

  26. Lunn, H. F. andRees, R. J. Treatment of mycobacterial skin ulcer in Uganda with a Riminophenazine derivative (B 663). Lancet (1964/II) 247–249.

    Google Scholar 

  27. Lunn, H. F. Effects of climate on the localisation and geographic distribution of mycobacterial skin ulcers. Dermatologia Internat. Philadelphia 4 (1965) 111–114.

    Google Scholar 

  28. Lunn, H. F., Connor, D. H., Wilks, N. E., Barnley, G. R., Kamunvi, F., Clancey, J. K. andBee, J. D. A. Buruli (Mycobacterial) ulceration in Uganda. (A new focus of Buruli ulcer in Madi District, Uganda) E. Afr. Med. J. 42 (1965) 275–288.

    Google Scholar 

  29. Mac Callum, P., Tolhurst, J. C., Buckle, G. andSissons, H. A. A new mycobacterial infection in man. J. Path. Bact. 60 (1948) 93–122.

    Google Scholar 

  30. Maegraith, B. Exotic diseases in practice. S. 116. Pitman Press, Bath 1965.

    Google Scholar 

  31. Meissner, G. Vorkommen und Eigenschaften (bakteriologisch und tierexperimentell) von atypischen Mycobakterien. Jber. Borstel 5 (1961) 408–480.

    Google Scholar 

  32. Meissner, G. Nichtklassifizierte Mykobakterien. In: Infektionskrankheiten des Menschen und ihre Erreger. Hrsg. vonA. Grumbach u.O. Bonin. S. 932–953. Georg Thieme Verlag, Stuttgart 1969.

    Google Scholar 

  33. Ngu, V. A. Tropical and other ulcers of the leg. Kap. V. S. 89–93. In: Tropical Surgery. Hrsg. vonS. I. Schwartz, A. O. Adesola, E. A. Elebute andC. G. Rob. McGraw Hill Book Comp., New York 1971.

    Google Scholar 

  34. Pattyn, S. R., Boveroulle, M. T., Gatti, F. u.Vandepitte, J. Étude des souches de Mycobacterium ulcerans isolées au Congo (Léopoldville). Acad. Roy. Sci. d'Outre-Mer Bull. des Séances (1964/VI) 1576–1599.

    Google Scholar 

  35. Pettit, J. S., Marchette, N. J. andRees, R. J. W. Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Brit. J. Dermat. 78 (1966) 187–197.

    Google Scholar 

  36. Reid, I. S. Mycobacterium ulcerans infection: a report of 13 cases at the Port Moresby General Hospital, Papua. Med. J. Aust. 1 (1967) 427–431.

    Google Scholar 

  37. Runyon, E. H. Anonymous mycobacteria in pulmonary disease. Med. Clin. N. Amer. 43 (1959) 273–290.

    Google Scholar 

  38. Shattock, F. M. Mycobacterial skin ulceration. E. Afr. Med. J. 42 (1965) 548–551.

    Google Scholar 

  39. Smith, J. H. Epidemiologic observations on cases of Buruli ulcer seen in a hospital in the Lower Congo. Amer. J. Trop. Med. Hyg. 19 (1970) 657–663.

    Google Scholar 

  40. The Uganda Buruli Group: BCG-vaccination against Mycobacterium ulcerans infection (Buruli ulcer). Lancet (1969/I) 111–115.

    Google Scholar 

  41. The Uganda Buruli Group: Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans. Roy. Soc. Trop. Med. Hyg. 65 (1971) 763–775.

    Google Scholar 

  42. Timpe, A. andRunyon, E. H. The relationship of atypical acidfast bacteria to human disease. A preliminary report. J. Lab. clin. Med. 44 (1954) 202–209.

    Google Scholar 

  43. Ullmann, U., Kieninger, G. u.Schubert, G. E.: Mikrobiologische und tierexperimentelle Untersuchungen mit Mycobacterium ulcerans (in Vorbereitung).

Download references

Author information

Authors and Affiliations

Authors

Additional information

Herrn Prof. Dr. med.R.-E. Bader zum 60. Geburtstag.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kieninger, G., Schubert, G.E., Ullmann, U. et al. Die Infektion des Menschen mit Mycobacterium ulcerans (Buruli-Ulkus). Infection 1, 46–52 (1973). https://doi.org/10.1007/BF01638256

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01638256

Navigation